MELISSA O'SULLIVAN: Open Payments
NPI 1710990205 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$659 in 39 payments from 16 companies in 2025. Trend: 2023 $338 · 2024 $627 · 2025 $659
Food & beverage: $659
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $138 |
| Lilly USA, LLC | 5 | $84 |
| Abbott Laboratories | 3 | $68 |
| PFIZER INC. | 4 | $68 |
| AstraZeneca Pharmaceuticals LP | 4 | $62 |
| ABBVIE INC. | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 3 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $17 |
Products named: Ozempic, MOUNJARO, FREESTYLE LIBRE 3, NURTEC ODT, FARXIGA, VRAYLAR, Wegovy, VOQUEZNA.
Industry payments across NC — which companies pay providers there.
